Phenox announces exclusive distribution agreement with Wallaby Medical for the Avenir Coil System in the USA and Europe

1085

phenox wallabyPhenox announces that it has signed an exclusive distribution agreement with Wallaby Medical for commercialisation of the Avenir Detachable Coil System in the US and EU markets. The intended use for the Avenir Coil System is for endovascular embolisation of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The Avenir Coil System is also intended for arterial and venous embolisation in the peripheral vasculature.

A press release states that the Avenir Coil System offers a full line of coils including exceptional stable framing coils, extra volume filling coils and ultra-soft finishing coils. Avenir has a streamlined and intuitive, integrated mechanical detachment mechanism with no handle or external energy source required. Furthermore, Avenir’s anatomically adaptive pusher with proprietary multi-filar technology along with its patent-pending elastic nitinol lasso detachment zone technology facilitates intracranial navigation while minimising microcatheter kick-out.

The Avenir Coil System has been used to successfully treat over 100 patients in the USA, China and Latin America and is expected to be officially launched in the USA and Europe later this year.

Professor Youxiang Li of Beijing Tiantan Hospital, Beijing, China, one of the largest treatment centres for brain aneurysms in the world, commented, “The Avenir coils provide smooth delivery and exceptional visibility during the procedure. The detachment is intuitive and instantaneous.”


LEAVE A REPLY

Please enter your comment!
Please enter your name here